Netter Healthcare Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 04-07-2024
- Paid Up Capital ₹ 3.16 M
as on 04-07-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 04-07-2024
- Revenue 27.93%
(FY 2023)
- Profit 21.96%
(FY 2023)
- Ebitda 41.12%
(FY 2023)
- Net Worth 116.43%
(FY 2023)
- Total Assets 32.44%
(FY 2023)
About Netter Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 3.16 M.
The company currently has active open charges totaling ₹5.00 M.
Gopinathan Kuruppath, Sony George, Lino Antony, and Five other members serve as directors at the Company.
- CIN/LLPIN
U51909KA2016PTC085826
- Company No.
085826
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Feb 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Netter Healthcare?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Nair  | Director | 04-Feb-2016 | Current |
| Sony George | Director | 02-May-2017 | Current |
| Gopinathan Kuruppath | Additional Director | 25-May-2022 | Current |
| Lino Antony | Director | 02-May-2017 | Current |
| Pillai Manojkumar | Director | 04-Feb-2016 | Current |
| Saratchandran Nair | Director | 02-May-2017 | Current |
Financial Performance of Netter Healthcare.
Netter Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.93% increase. The company also saw a substantial improvement in profitability, with a 21.96% increase in profit. The company's net worth Soared by an impressive increase of 116.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Netter Healthcare?
In 2023, Netter Healthcare had a promoter holding of 22.14% and a public holding of 77.86%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Troika Health Care Private LimitedActive 7 years 7 daysVinod Nair and Pillai Manojkumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Dec 2023 | ₹5.00 M | Open |
How Many Employees Work at Netter Healthcare?
Unlock and access historical data on people associated with Netter Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Netter Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Netter Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
